Frontlight ResearchEarly access
Colorectal cancer trials in United States
455 of 551 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Taking peopleActive Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 120
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03594630 - Phase 1Taking peopleMetarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Where
- Bethesda, Fairway
- Age
- 12 years to 120 years
- People
- 116
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04222413 - Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Aurora, Boston, Cleveland, Durham, Fairfax, Gilbert, Grand Rapids, Houston, Los Angeles, Minneapolis, Nashville, New Haven, New York, San Antonio, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 623 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1/2Taking peopleA Phase 1/2 Study of IAM1363 in HER2 Cancers
- Where
- Ann Arbor, Aurora, Austin, Boston, Chicago, Cleveland, Dallas, Detroit, Durham, Fairfax, Grand Rapids, Houston, Kansas City, La Jolla, Lebanon, Los Angeles, Miami, Nashville, New Brunswick, New York, Oklahoma City, Portland, Seattle, St Louis, St. Petersburg, West Valley City
- Age
- 18 years and over
- People
- 463 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 · EU 2024-519188-17-00 - Phase 1Taking peopleA Study of VET3-TGI in Patients With Solid Tumors
- Where
- Dallas, Houston, Indianapolis, Los Angeles, Miami, Orange, Pittsburgh, Seattle
- Age
- 18 years and over
- People
- 60
- Run by
- KaliVir Immunotherapeutics
See details and how to joinNCT06444815 - Phase 1Taking peopleA Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Where
- Duarte, Glen Burnie, Grand Rapids, Houston, Iowa City, Irvine, Miami, New York, Orlando, Pittsburgh, Salt Lake City, Tampa, Westwood
- Age
- 18 years and over
- People
- 150
- Run by
- Aktis Oncology, Inc.
See details and how to joinNCT07020117 - Phase 2Taking peopleA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Where
- Chapel Hill, Charlottesville, Cleveland, Coral Springs, East Brunswick, Fairfax, Fort Worth, Grand Rapids, Houston, Indianapolis, Los Angeles, Madison, Nashville, New York, Salt Lake City, Scottsdale, Seattle, St Louis, Tamarac, Tampa, West Valley City
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Verastem, Inc.
See details and how to joinNCT07659795 · EU 2026-526473-42-00 - Phase 1Not yet taking people in United StatesHepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 20
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07715903 - Phase 2Not yet taking people in United StatesA Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
- Where
- Chapel Hill, Duarte, Fairfax, Flower Mound, Glendale, Houston, Irvine, Nashville, Pittsburgh, Rockville, Seattle, Webster, Zion
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07823322 - Phase 2Not yet taking people in United StatesA Vaccine (Nous-209) for the Reduction of Colorectal Lesion Size in Patients With Lynch Syndrome
- Where
- Ann Arbor, Boston, Houston, Kansas City, Philadelphia
- Age
- 18 years and over
- People
- 55
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07937696 - Phase 3Taking peopleTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Where
- Allentown, Ann Arbor, Atlanta, Aurora, Aventura, Basking Ridge, Birmingham, Buffalo, Carmel, Chicago, City of Saint Peters, Cleveland, Columbus, Commack, Coral Gables, Creve Coeur, Dallas, Deerfield Beach, Durham, East White Plains, Erie, Fort Worth, Gilbert, Grand Rapids, Hollywood, Indianapolis, Jefferson Hills, Lexington, Madison, Miami, Middletown, Minneapolis, Monroeville, Montvale, Nashville, New York, Philadelphia, Phoenix, Pittsburgh, Plantation, Portland, Raleigh, Richardson, Rochester, Shiloh, St Louis, Sun City, Uniondale, Wexford, Winston-Salem, Youngstown
- Age
- 18 years and over
- People
- 408
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT05863195 - Phase 1/2Taking peopleBeamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Where
- Ann Arbor, Boston, Cerritos, Fairfax, Hershey, Houston, Indianapolis, Iowa City, Lakeland, Los Angeles, Memphis, Nashville, New Haven, New York, Orange, San Diego, Seattle, Shirley, Sioux Falls, Skokie, Tampa
- Age
- 18 years and over
- People
- 910 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06324357 - Phase 1/2Taking peopleA Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Where
- Fairfax, Houston, San Antonio
- Age
- 18 years to 75 years
- People
- 570 worldwide
- Run by
- Tyligand Pharmaceuticals (Suzhou) Limited
See details and how to joinNCT06385925 - Phase 1Taking peopleA Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Where
- Atlanta, Aurora, Boston, Fairfax, Houston, New York, Santa Rosa, Sarasota, Tampa, Tyler
- Age
- 18 years to 99 years
- People
- 600 worldwide
- Run by
- Erasca, Inc.
See details and how to joinNCT06983743 · EU 2026-525794-39-00 - Phase 1/2Taking peopleA Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Where
- Aurora, Canton, Detroit, Nashville
- Age
- 18 years and over
- People
- 47 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07213609 - Early phase 1Taking peopleGLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- Where
- Tucson
- Age
- 18 years to 99 years
- People
- 30
- Run by
- University of Arizona
See details and how to joinNCT07627191 - Phase 3Taking peopleStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
- Where
- Babylon, Hot Springs, Los Angeles, Olympia, Savannah, Tampa
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Genmab
See details and how to joinNCT07775287 - Phase 2Not yet taking people in United StatesA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
- Where
- Ann Arbor, Detroit, Morgantown, Tucson
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Vividion Therapeutics, Inc.
See details and how to joinNCT07811193 · EU 2026-525507-26-00 - Phase 1/2Taking peopleSumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Full-Life Technologies UK Limited
See details and how to joinNCT07873450 - Phase 1/2Not yet taking people in United StatesA Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- San Antonio, West Valley City
- Age
- 18 years and over
- People
- 171 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07939815 - Phase 2Taking peopleA Study of Tucatinib and Trastuzumab in People With Rectal Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 37
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05672524 - No phaseTaking peopleInitial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
- Where
- Houston, Orlando
- Age
- 22 years and over
- People
- 30
- Run by
- GI Windows, Inc.
See details and how to joinNCT07276529 - Phase 1/2Taking peopleA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Where
- Atlanta, Austin, Basking Ridge, Birmingham, Commack, Detroit, Durham, Fairfax, Grand Rapids, Hackensack, Harrison, Houston, Indianapolis, Irving, Lake Success, Lebanon, Long Island City, Los Angeles, Madison, Miami, Middletown, Montvale, New Brunswick, Oklahoma City, Orange, Saint Louis Park, Salt Lake City, San Antonio, Seattle, Uniondale, West Valley City
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07488676 - Phase 1/2Taking peopleA Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Where
- Fairfax, Houston
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SOTIO Biotech a.s.
See details and how to joinNCT07693751 · EU 2026-526235-19-00 - Phase 2Taking peopleImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 332
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01174121